Jump to content

TLK286


Guest

Recommended Posts

This was mentioned by Peg a while ago. Though her husband is on Iressa and seems to be doing well :D

I have read before that "whey protein" may reduce glutathione in cancer cells and make them more sensitive to chemo.

Novel Glutathione Leads To Longer Remission In Ovarian Cancer

Previously treated ovarian cancer patients, who have failed after first line drugs such as taxol and platins, represebnt a difficult type of patient to successfully treat. Conventional agents such as topotecan and liposomal doxorubicin are attended with median survival rates of 35-40 weeks in this second line chemotherapy situation. In a recently reported trial from the USA, a new drug TLK286 (Telik Inc. San Francisco) a glutsathione (activated in cancer cells by glutathionbe S transferase) achieved a 56 week median survival in this situation - a result that is crying out for repeating by others and a spark for further research in hihs field.

6 May 2003

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.